MXPA94000705A - Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions. - Google Patents
Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions.Info
- Publication number
- MXPA94000705A MXPA94000705A MX9400705A MX9400705A MXPA94000705A MX PA94000705 A MXPA94000705 A MX PA94000705A MX 9400705 A MX9400705 A MX 9400705A MX 9400705 A MX9400705 A MX 9400705A MX PA94000705 A MXPA94000705 A MX PA94000705A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical compositions
- change
- hypothalamic function
- related pharmaceutical
- estrene
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 4
- -1 Estrene steroids Chemical class 0.000 title abstract 3
- 230000002267 hypothalamic effect Effects 0.000 title abstract 2
- 239000003999 initiator Substances 0.000 title 1
- 230000001722 neurochemical effect Effects 0.000 title 1
- 239000003620 semiochemical Substances 0.000 abstract 2
- 150000003431 steroids Chemical class 0.000 abstract 2
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
Landscapes
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a method of altering hypothalamic function in an individual. The method comprises nasally administering a human semiochemical, e.g. an Estrene steroid, or a pharmaceutical composition containing an Estrene steroid, such that the ligand semiochemical binds to a specific neuroepithelial receptor. The steroid is preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers. Other embodiments of the invention include pharmaceutical compositions containing the steroids.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7714093A | 1993-06-15 | 1993-06-15 | |
| US08/127,980 US5783571A (en) | 1991-01-07 | 1993-09-28 | Method of altering hypothalamic function by nasal administration of estrene steroids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA94000705A true MXPA94000705A (en) | 2004-08-20 |
Family
ID=26758941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9400705A MXPA94000705A (en) | 1993-06-15 | 1994-01-27 | Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions. |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN1101648A (en) |
| MX (1) | MXPA94000705A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111532108A (en) * | 2020-05-12 | 2020-08-14 | 中国科学院心理研究所 | New uses of estratetraene |
| JP2023527288A (en) * | 2020-05-18 | 2023-06-28 | ヴィスタゲン セラピューティクス、インコーポレイテッド | Treatment of adjustment disorders |
-
1994
- 1994-01-27 MX MX9400705A patent/MXPA94000705A/en active IP Right Grant
- 1994-06-15 CN CN 94106649 patent/CN1101648A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN1101648A (en) | 1995-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2223397A1 (en) | Novel nor-pregnanes for inducing hypothalamic effects | |
| AU5587690A (en) | Treatment of postmenopausal disorders | |
| HK26087A (en) | Method of contraception and pharmaceutical package therefor | |
| MD1920F2 (en) | Composititon and method of prevention and delay of the Alzheimer's disease origin | |
| EP1340502A3 (en) | Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods | |
| HU9503579D0 (en) | Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods | |
| CA2258177A1 (en) | 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function | |
| AU3963797A (en) | Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety | |
| MX9702253A (en) | Novel estrenes for inducing hypothalamic effects. | |
| MXPA94000705A (en) | Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions. | |
| CA2196690A1 (en) | Pregnanes and cholanes as neurochemical initiators of change in hypothalamic function | |
| GB1488995A (en) | Compositions containing anti-androgenic compounds | |
| CA2248841A1 (en) | Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy | |
| TW289730B (en) | Pharmaceutical composition for alleviating the symptoms of psychoses, depression or anxiety comprising androstene steroids | |
| BR9816142A (en) | 19-nor-colano steroids as neurochemical initiators of change in human hypothalamic function | |
| IL108155A0 (en) | Pharmaceutical compositions containing 17 alphadihydroequilenin or an ester or salt thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |